Skip to content
2000
Volume 3, Issue 4
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

In the last decades the epidermal growth factor receptor (EGFR), which is frequently expressed in a variety of epithelial tumors, has been a major target of molecular anticancer therapy.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/157339407782496988
2007-11-01
2025-05-19
Loading full text...

Full text loading...

/content/journals/cctr/10.2174/157339407782496988
Loading

  • Article Type:
    Research Article
Keyword(s): EGFR; Monoclonal antibody; resistance; Tyrosine kinase inhibitor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test